Perspective Therapeutics CATX
NYSE CATX
$2.73 +0.12 (+4.39%)
As of: Sep 30, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Share-based Compensation (2010 - 2026)

Updated

Perspective Therapeutics (CATX) reported Share-based Compensation of $3.05 million for Q2 2026, up 26.8% from $2.4 million a year earlier and up 19.3% from the prior quarter.

Analysis

Perspective Therapeutics (CATX) Share-based Compensation (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Perspective Therapeutics' Share-based Compensation came in at $10.06 million, up 18.2% year-over-year; for FY2025, it came in at $8.97 million, up 66.4% from FY2024.

  • Share-based Compensation has increased for three consecutive years, with a five-year compound annual growth rate of 78.5% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $5.39 million in FY2024 (+44.1%), $3.74 million in FY2023 (+280.3%), $983,000 in FY2022 and $386,000 in FY2021 (-22.0%).
  • The Q2 2026 figure ranks as the highest quarterly Share-based Compensation in data going back to Q4 2022.
  • Year over year, Share-based Compensation has now increased in each of the last eight quarters, with growth averaging 130.5% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q3 2024 (growth of 332.8%); the low point was Q1 2024 (a decline of 52.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.55 million (Q1 2026), $2.31 million (Q4 2025) and $2.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 458.00 Mn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 166.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 170.20 Mn
10 Perspective Therapeutics 298.91 Mn 298.91 Mn - 3.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.05 Mn
Mar 31, 2026 2.55 Mn
Dec 31, 2025 2.31 Mn
Sep 30, 2025 2.16 Mn
Jun 30, 2025 2.40 Mn
Mar 31, 2025 2.10 Mn
Dec 31, 2024 2.06 Mn
Sep 30, 2024 1.95 Mn
Jun 30, 2024 719,000.00
Mar 31, 2024 656,000.00
Dec 31, 2023 720,000.00
Sep 30, 2023 451,000.00
Jun 30, 2023 1.20 Mn
Mar 31, 2023 1.37 Mn
Dec 31, 2022 -261,000.00
Sep 30, 2022 465,000.00
Mar 31, 2022 157,000.00
Dec 31, 2021 311,000.00
Sep 30, 2021 596,000.00
Jun 30, 2021 126,000.00
API Access

Perspective Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CATX&period=max&api_key=YOUR_API_KEY